Cargando…
Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991225/ http://dx.doi.org/10.1186/2051-1426-1-S1-O6 |
| _version_ | 1782312399517253632 |
|---|---|
| author | Callahan, Margaret K Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D |
| author_facet | Callahan, Margaret K Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D |
| author_sort | Callahan, Margaret K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39912252014-05-05 Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab Callahan, Margaret K Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991225/ http://dx.doi.org/10.1186/2051-1426-1-S1-O6 Text en Copyright © 2013 Callahan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Callahan, Margaret K Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab |
| title | Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab |
| title_full | Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab |
| title_fullStr | Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab |
| title_full_unstemmed | Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab |
| title_short | Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab |
| title_sort | peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-pd-1, bms-936558, ono-4538) and ipilimumab |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991225/ http://dx.doi.org/10.1186/2051-1426-1-S1-O6 |
| work_keys_str_mv | AT callahanmargaretk peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT horakchristinee peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT curranmichaela peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT hollmantravis peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT schaerdavida peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT yuanjianda peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT lesokhinalexanderm peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT kitanoshigehisa peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT hongquan peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT ariyancharlottee peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT busamklausj peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT feelywilliam peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT jurekunkelmaria peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT grossojoseph peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT simonjasons peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT kormanalanj peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT wiggintonjonm peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT guptaashokk peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT zhangxiaoling peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT phillipstherese peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT simmonspauline peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT sznolmario peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab AT wolchokjeddd peripheralbloodandtumorbiomarkersinpatientswithadvancedmelanomatreatedwithcombinationnivolumabantipd1bms936558ono4538andipilimumab |